Literature DB >> 3631730

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival.

R E Chaisson, G F Schecter, C P Theuer, G W Rutherford, D F Echenberg, P C Hopewell.   

Abstract

Tuberculosis has been reported previously in patients with acquired immunodeficiency syndrome who are at increased risk of prior infection with Mycobacterium tuberculosis. We performed a population-based study of AIDS and tuberculosis in San Francisco using the Tuberculosis and AIDS Registries of the San Francisco Department of Public Health. Of 287 cases of tuberculosis in non-Asian-born males 15 to 60 yr of age reported from 1981 through 1985, 35 (12%) also had AIDS, including 23 American-born whites. Patients with tuberculosis and AIDS were more likely to be nonwhite and heterosexual intravenous drug users than were AIDS patients without tuberculosis. Fifty-one percent had tuberculosis diagnosed before AIDS, and 37 percent had AIDS diagnosed at least 1 month prior to the diagnosis of tuberculosis. Although the lungs were the most frequent site of tuberculosis in both AIDS and non-AIDS patients, 60% of the AIDS group had at least 1 extrapulmonary site of disease compared to 28% of the non-AIDS group (p less than 0.001). Nonsignificant tuberculin skin tests were more common in AIDS patients (14 of 23 patients tested) than in non-AIDS patients (12 of 129 patients tested; p less than 0.0001). Chest radiographs in AIDS patients showed predominantly diffuse or miliary infiltrates (60%), whereas non-AIDS patients had predominantly focal infiltrates and/or cavitation (68%). Response to antituberculosis therapy was favorable in AIDS patients, although adverse drug reactions occurred more frequently than in non-AIDS patients (p less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3631730     DOI: 10.1164/ajrccm/136.3.570

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  91 in total

1.  Mixed bronchial infection due to Mycobacterium tuberculosis and Mycobacterium avium-intracellulare in an AIDS patient.

Authors:  M Libanore; R Bicocchi; F Ghinelli
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

Review 2.  HIV infection and tuberculosis.

Authors:  J M Watson; O N Gill
Journal:  BMJ       Date:  1990-01-13

Review 3.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 4.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

5.  Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients.

Authors:  P Tabarsi; E Chitsaz; A Moradi; P Baghaei; P Farnia; M Marjani; M Shamai; M Amiri; S Nikaein; D Mansouri; M Masjedi; F Altice
Journal:  Int J STD AIDS       Date:  2012-09       Impact factor: 1.359

Review 6.  Tuberculosis in patients with human immunodeficiency virus infection. Review of current concepts.

Authors:  C P Theuer
Journal:  West J Med       Date:  1989-06

7.  Tuberculous pericarditis as the first manifestation of AIDS.

Authors:  J Pedro-Botet; T Auguet; J Coll; S Pons; J Rubiés-Prat
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

Review 8.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

Review 9.  Gastrointestinal tuberculosis.

Authors:  Todd A Sheer; Walter J Coyle
Journal:  Curr Gastroenterol Rep       Date:  2003-08

10.  Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis.

Authors:  Donatella Vincenti; Stefania Carrara; Patrizia De Mori; Leopoldo P Pucillo; Nicola Petrosillo; Fabrizio Palmieri; Orlando Armignacco; Giuseppe Ippolito; Enrico Girardi; Massimo Amicosante; Delia Goletti
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.